A Vision for Our Future: The Value Initiative
In 2016 the SNMMI leadership team met to discuss ways that the field of nuclear medicine and molecular imaging is changing and how to address related challenges in a new strategic plan. They envisioned a plan that would provide a roadmap for dealing with those challenges and demonstrating the true value of the field to a broad set of stakeholders: medical students and professionals, industry partners, regulators, patients, and the public.
The Value Initiative comprises six domains related to the organization’s work: Quality of Practice, Research and Discovery, Workforce Pipeline and Life-Long Learning, Advocacy, Outreach, and Organizational Strength and Stability. These domains will form the basis of a new strategic plan for adoption in 2017, adding a new layer of value to the Society’s existing work and ultimately bringing that value to patients, the medical field, and society at large. In collaboration with other medical societies and organizations, the society will lead a transformation in the nuclear medicine and molecular imaging field.
Domain One: Quality of Practice
Chair: Gary L. Dillehay, MD, FACNM, FACR, FSNMMI; Northwestern Memorial Hospital
The goal of this domain is to ensure that SNMMI members are known for high-quality, value-driven performance, and delivery of patient-centered nuclear medicine practice. To achieve the high-quality desired health outcomes, SNMMI will continue to pave way for the delivery of efficient, effective and patient-centered nuclear medicine practice by its members. Learn more.
Domain Two: Research and Discovery
Chair: Richard L. Wahl, MD, FACNM; Washington University School of Medicine
The goal of this domain is that SNMMI advance the development and approval of nuclear medicine and molecular imaging technologies, including therapies. Realizing that innovation is essential for our field, our science should promote and encourage these advancements. Sufficient funding is an overarching issue for research, and we will strive to increase funding from a variety of sources. Learn more.
Domain Three: Workforce Pipeline and Life-Long Learning
Chair: Frederick D. Grant, MD; Boston Children's Hospital
The goal of this domain is to ensure that SNMMI will continue to innovate and collaborate to retain and expand the diverse pool of qualified professionals working in the field, making society the epicenter of all things related to nuclear medicine. Learn more.
Domain Four: Advocacy
Chair: Munir Ghesani, MD, FACNM; NYU Langone Medical Center
Central to the Advocacy domain are efforts to promote awareness among policymakers about the NM/MI field. Paramount in this area is cooperative work with other organizations and outreach with regulatory agencies and the legislature to advocate for a better approval, coverage and reimbursement process for NM/MI drugs, devices, diagnostic procedures, and therapies. Learn more.
Domain Five: Outreach
Chair: Vasken Dilsizian, MD; University of Maryland School of Medicine
The goal of this domain is to ensure that patients and the medical community recognize the value of nuclear medicine, molecular imaging and radionuclide therapy. We will focus on promoting nuclear medicine and positioning SNMMI as the worldwide leader in molecular imaging and radionuclide therapy. Learn more.
Domain Six: Organizational Strength and Stability
SNMMI has the organizational strength and sustainability to lead the field in a dynamic healthcare landscape.